THE CHANGING EPIDEMIOLOGY OF INVASIVE MENINGOCOCCAL-DISEASE IN CANADA, 1985 THROUGH 1992 - EMERGENCE OF A VIRULENT CLONE OF NEISSERIA-MENINGITIDIS

被引:147
作者
WHALEN, CM
HOCKIN, JC
RYAN, A
ASHTON, F
机构
[1] HLTH & WELF CANADA,HLTH PROTECT BRANCH,LAB CTR DIS CONTROL,BUR COMMUNICABLE DIS EPIDEMIOL,OTTAWA,ON K1A 0L2,CANADA
[2] HLTH & WELF CANADA,HLTH PROTECT BRANCH,LAB CTR DIS CONTROL,BUR MICROBIOL,NATL LAB BACTERIOL,OTTAWA,ON K1A 0L2,CANADA
[3] UNIV OTTAWA,DEPT EPIDEMIOL & COMMUNITY MED,OTTAWA,ON,CANADA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1995年 / 273卷 / 05期
关键词
D O I
10.1001/jama.273.5.390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-To describe the occurrence of invasive meningococcal disease (IMD) in Canada with respect to demographic variables and characteristics of the isolated strains of Neisseria meningitidis. Design.-National surveillance case series. Setting.-Canada, 1985 through 1992. Outcome Measures.-Morbidity and mortality. Main Results.-The incidence of IMD averaged 1.38 per 100 000 person-years, with considerable regional variation. In 1988, serogroup C organisms became more common, with one strain of the electrophoretic type 37 (ET-37) complex of N meningitidis,termed ET-15, the predominant group C strain identified. With the increase in group C disease, a greater proportion of cases were older than 5 years. By 1991, ET-15 was the most common strain identified in most parts of the country. Electrophoretic type 15 had a case fatality of 17.8% vs 8.1% for all other IMD (P<.001). Among cases 20 years and older the case fatality for ET-15 was 22.4%. Conclusions.-The group C, ET-15 strain of N meningitidis, first identified in Canada, was more virulent than other prevalent strains during this period, Active surveillance, rapid identification, and typing of N meningitidis will assist public health decision making in the control of emerging strains.
引用
收藏
页码:390 / 394
页数:5
相关论文
共 43 条
  • [1] EMERGENCE OF A VIRULENT CLONE OF NEISSERIA-MENINGITIDIS SEROTYPE-2A THAT IS ASSOCIATED WITH MENINGOCOCCAL GROUP-C DISEASE IN CANADA
    ASHTON, FE
    RYAN, JA
    BORCZYK, A
    CAUGANT, DA
    MANCINO, L
    HUANG, D
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (11) : 2489 - 2493
  • [2] BAKER CJ, 1983, PEDIATRICS, V71, P923
  • [3] BOUCHARD F, 1992, CAN J PUBLIC HEALTH, V83, P131
  • [4] INFLUENZA-A AND MENINGOCOCCAL DISEASE
    CARTWRIGHT, KAV
    JONES, DM
    SMITH, AJ
    STUART, JM
    KACZMARSKI, EB
    PALMER, SR
    [J]. LANCET, 1991, 338 (8766) : 554 - 557
  • [5] A CHANGE IN MENINGOCOCCAL SEROGROUPS IN THE WEST OF IRELAND
    CORBETTFEENEY, G
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 1991, 160 (05) : 134 - 138
  • [6] IMMUNOLOGICAL INVESTIGATIONS OF MENINGOCOCCAL DISEASE .3. BREVITY OF GROUP-C ACQUISITION PRIOR TO DISEASE OCCURRENCE
    EDWARDS, EA
    DEVINE, LF
    SENGBUSCH, CH
    WARD, HW
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1977, 9 (02) : 105 - 110
  • [7] FALLON RJ, 1988, J MED MICROBIOL, V26, P161
  • [8] FARLEY JD, 1992, CAN J PUBLIC HEALTH, V83, P138
  • [9] GEMMILL I, 1992, CAN J PUBLIC HEALTH, V83, P134
  • [10] GOLD R, 1992, CAN J PUBLIC HEALTH, V83, P5